• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核后阻塞性气道疾病和慢性阻塞性肺疾病的治疗结果:一项前瞻性队列研究。

Treatment outcome among Post TB obstructive airways diseases and COPD: A prospective cohort study.

作者信息

Swain Smrutirekha, Pothal Sudarsan, Behera Aurobindo, Manjhi Rekha, Dutta Pravati, Pradhan Gourahari

机构信息

V.S.S. Institute of Medical Sciences & Research, Burla, Odisha, India.

出版信息

J Family Med Prim Care. 2021 Sep;10(9):3411-3416. doi: 10.4103/jfmpc.jfmpc_2391_20. Epub 2021 Sep 30.

DOI:10.4103/jfmpc.jfmpc_2391_20
PMID:34760766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8565138/
Abstract

CONTEXT

Post Tubercular Obstructive Airways Diseases (Post-TB OAD) is a sequela of Pulmonary TB but diseases progression may not same like Chronic Obstructive Pulmonary Diseases (COPD).

AIM

To compare the frequency and severity of exacerbations, change of FEV1, frequency of hospitalization and mortality among COPD and post TB OAD patients.

SETTING AND DESIGN

Hospital-based prospective cohort study.

METHODS AND MATERIAL

COPD cohort was diagnosed based on symptoms, history of exposure to risk factors and post bronchodilator FEV1/FVC ratio <70%. Post TB OAD cohort was diagnosed like COPD along with past history of Pulmonary TB. Both cohorts were followed up every 3-monthly intervals for up to 12 months.

STATISTICAL ANALYSIS

Comparison of categorical variable was done by Chi-square test and continuous variable by unpaired t test. Longitudinal data of FEV1% were analyzed by repeated measure ANOVA test.

RESULTS

Totally, 68 patients with Post TB OAD and 66 COPD patients were taken into this study. The frequency of exacerbation (3.52 ± 1.84 verses 2.70 ± 1.37), number of severe exacerbation (56 verses 24) and frequency of hospitalization (1.37 ± 0.81 verses 0.97 ± 0.94) more seen in post-TB OAD cohort in compared to COPD cohort which is statistically significant. Mortality more seen in post-TB OAD group (14 verses 6). Rate of decline FEV1 per year more seen in Post-TB OAD (0.27 ± 0.28 lit verses 0.17 ± 0.26 liter) as compared to COPD. There was overall decreasing trend of FEV1% over period of 12 month but without any difference among two cohort.

CONCLUSION

There was more in frequency of exacerbations, number of severe exacerbations, frequency of hospitalization and number of mortalities among post TB OAD compared to COPD.

摘要

背景

结核后阻塞性气道疾病(Post-TB OAD)是肺结核的后遗症,但疾病进展可能与慢性阻塞性肺疾病(COPD)不同。

目的

比较慢性阻塞性肺疾病(COPD)和结核后阻塞性气道疾病(Post-TB OAD)患者急性加重的频率和严重程度、第一秒用力呼气容积(FEV1)的变化、住院频率和死亡率。

设置与设计

基于医院的前瞻性队列研究。

方法和材料

COPD队列根据症状、危险因素暴露史和支气管扩张剂使用后FEV1/FVC比值<70%进行诊断。结核后阻塞性气道疾病(Post-TB OAD)队列除了有肺结核病史外,诊断方法与COPD相同。两个队列均每3个月随访一次,为期12个月。

统计分析

分类变量采用卡方检验进行比较,连续变量采用非配对t检验进行比较。FEV1%的纵向数据采用重复测量方差分析进行分析。

结果

本研究共纳入68例结核后阻塞性气道疾病(Post-TB OAD)患者和66例COPD患者。与COPD队列相比,结核后阻塞性气道疾病(Post-TB OAD)队列的急性加重频率(3.52±1.84对2.70±1.37)、严重急性加重次数(56对24)和住院频率(1.37±0.81对0.97±0.94)更高,差异具有统计学意义。结核后阻塞性气道疾病(Post-TB OAD)组的死亡率更高(14对6)。与COPD相比,结核后阻塞性气道疾病(Post-TB OAD)每年FEV1下降率更高(0.27±0.28升对0.17±0.26升)。在12个月期间,FEV1%总体呈下降趋势,但两个队列之间无差异。

结论

与COPD相比,结核后阻塞性气道疾病(Post-TB OAD)的急性加重频率、严重急性加重次数、住院频率和死亡人数更多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f6b/8565138/27d07771ff35/JFMPC-10-3411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f6b/8565138/27d07771ff35/JFMPC-10-3411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f6b/8565138/27d07771ff35/JFMPC-10-3411-g001.jpg

相似文献

1
Treatment outcome among Post TB obstructive airways diseases and COPD: A prospective cohort study.肺结核后阻塞性气道疾病和慢性阻塞性肺疾病的治疗结果:一项前瞻性队列研究。
J Family Med Prim Care. 2021 Sep;10(9):3411-3416. doi: 10.4103/jfmpc.jfmpc_2391_20. Epub 2021 Sep 30.
2
Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary Disease: Baseline Results from a Prospective Cohort Study.既往肺结核对慢性阻塞性肺疾病的影响:一项前瞻性队列研究的基线结果。
Comb Chem High Throughput Screen. 2023;26(1):93-102. doi: 10.2174/1386207325666220406111435.
3
Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.β受体阻滞剂在中重度慢性阻塞性肺疾病中的应用
Med Arch. 2019 Apr;73(2):72-75. doi: 10.5455/medarh.2019.73.72-75.
4
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.低剂量茶碱口服联合吸入皮质激素治疗慢性阻塞性肺疾病且有加重高风险的患者:一项 RCT 研究。
Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.
5
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
6
[Incidence of severe exacerbation in patients diagnosed with diabetes and chronic obstructive pulmonary disease: Cohort study].[糖尿病合并慢性阻塞性肺疾病患者严重加重的发生率:队列研究]
Aten Primaria. 2021 Oct;53(8):102074. doi: 10.1016/j.aprim.2021.102074. Epub 2021 May 23.
7
The accuracy of patient history, wheezing, and laryngeal measurements in diagnosing obstructive airway disease. CARE-COAD1 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease.患者病史、哮鸣音及喉部测量在诊断阻塞性气道疾病中的准确性。CARE-COAD1组。慢性阻塞性气道疾病检查可靠性的临床评估。
JAMA. 2000 Apr 12;283(14):1853-7. doi: 10.1001/jama.283.14.1853.
8
Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.无慢性阻塞性肺疾病个体的类似急性加重的呼吸道症状:一项基于人群研究的结果
Thorax. 2014 Aug;69(8):709-17. doi: 10.1136/thoraxjnl-2013-205048. Epub 2014 Apr 4.
9
The role of tuberculosis in COPD.结核病在慢性阻塞性肺疾病中的作用。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:323-329. doi: 10.2147/COPD.S116086. eCollection 2017.
10
Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.慢性阻塞性肺疾病中急性加重对通过强迫振荡技术测量的呼吸系统阻抗的影响:一项前瞻性观察研究。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 3;12:509-516. doi: 10.2147/COPD.S124828. eCollection 2017.

引用本文的文献

1
Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis.低收入和中等收入国家慢性阻塞性肺疾病及肺结核后遗症的经济负担:基于系统评价和荟萃分析编制的数据库
BMJ Public Health. 2024 Jul 30;2(1):e000441. doi: 10.1136/bmjph-2023-000441. eCollection 2024 Jun.
2
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease: A Protocol for a Multicenter Prospective Cohort Study in China.肺结核相关性慢性阻塞性肺疾病的临床特征、治疗及预后:一项中国多中心前瞻性队列研究方案
Int J Chron Obstruct Pulmon Dis. 2024 Sep 25;19:2097-2107. doi: 10.2147/COPD.S475451. eCollection 2024.
3

本文引用的文献

1
Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease.肺结核气流阻塞患者和烟草相关慢性阻塞性肺疾病患者痰液中的细胞因子谱。
BMC Immunol. 2020 Oct 1;21(1):52. doi: 10.1186/s12865-020-00381-w.
2
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis.耐药和敏感结核病后遗症的功能影响。
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):700-705. doi: 10.5588/ijtld.19.0809.
3
Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.
Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study.肺结核幸存者发生慢性阻塞性肺疾病及相关住院的风险增加:基于人群的匹配队列研究。
J Korean Med Sci. 2024 Mar 25;39(11):e105. doi: 10.3346/jkms.2024.39.e105.
4
Post-tuberculosis lung diseases: Beyond treatment outcome.肺结核后肺部疾病:超越治疗结果
J Family Med Prim Care. 2022 May;11(5):2258-2259. doi: 10.4103/jfmpc.jfmpc_2066_21. Epub 2022 May 14.
马拉维肺结核后肺损伤相关的患者结局:一项前瞻性队列研究。
Thorax. 2020 Mar;75(3):269-278. doi: 10.1136/thoraxjnl-2019-213808. Epub 2020 Feb 26.
4
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic.肺结核后的死亡率和发病率:评估这一隐匿的流行病。
Lancet Respir Med. 2020 Apr;8(4):332-333. doi: 10.1016/S2213-2600(20)30039-4. Epub 2020 Feb 10.
5
Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction.体重指数对轻度至中度气流受限患者病情加重及医疗费用的影响。
Int J Chron Obstruct Pulmon Dis. 2018 Jul 27;13:2261-2269. doi: 10.2147/COPD.S163000. eCollection 2018.
6
Tuberculosis and lung damage: from epidemiology to pathophysiology.结核病与肺部损伤:从流行病学到病理生理学。
Eur Respir Rev. 2018 Feb 28;27(147). doi: 10.1183/16000617.0077-2017. Print 2018 Mar 31.
7
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异:1990-2016 年印度各邦的疾病流行转变的流行病学差异,全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
8
Clinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.患有结核后阻塞性气道疾病的印度人群的临床放射学和肺功能特征
J Clin Diagn Res. 2017 Mar;11(3):OC35-OC38. doi: 10.7860/JCDR/2017/24555.9529. Epub 2017 Mar 1.
9
The role of tuberculosis in COPD.结核病在慢性阻塞性肺疾病中的作用。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:323-329. doi: 10.2147/COPD.S116086. eCollection 2017.
10
Tuberculosis and chronic respiratory disease: a systematic review.结核病与慢性呼吸道疾病:一项系统综述
Int J Infect Dis. 2015 Mar;32:138-46. doi: 10.1016/j.ijid.2014.12.016.